EARLY TAVR published. Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes, driven by the latter. The study's

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS dlvr.it/TFprN9

#AHA24 Late-breaking trials: Left Atrial Appendage Closure after Ablation for Atrial Fibrillation Alessandro Sticchi provides his take✍️on the results 📊 of the OPTION Trial. 🔗pcronline.com/News/Whats-new… #LAAC #interventionalcardiology #atrialfibrillation #AFib #cardiotwitter

Coronary Physiological Indexes to Evaluate Myocardial Ischemia in Patients With Aortic Stenosis Undergoing Valve Replacement: JACC Journals 🥸 Do rely on FFR/DFR in AS patients undergoing AVR? 😱 Does AS mask coronary physiology?? 👇👇👇

I must confess that when I saw the results of the TCW trial at EuroPCR, which, by the way, was presented in a session that didn’t receive much attention, I thought the results were too good to be true. The non-inferiority margin seemed too wide, and I doubted we would see the

In pts w/ severe #vhdAS & #cvCAD, FFR ≤0.83 & RFR ≤0.85 appear to predict myocardial #ischemia more accurately. 6 months after AVR, FFR 📉, whereas RFR 📈 sig w/ a simultaneous decrease of LV mass & an improvement of microvascular function. jacc.org/doi/10.1016/j.… #JACCINT

PCR Perspectives: Ole De Backer and Maarten Vanhaverbeke Maarten Vanhaverbeke discuss the optimal #TAVI access approach in contemporary practice 📺pcronline.com/Cases-resource… #TAVR #FOAmed

Recognize the cute device bouncing in the LAA? Two years after transcatheter mitral paravalvular leak closure — Amplatzer device found embolized to the left atrial appendage. A reminder: closure success is more than the immediate result #CardioTwitter #StructuralHeart PCRonline 🫀

🧩 Tricuspid annuloplasty is gaining ground—but is it enough? Discussing the evolving role of annuloplasty devices like the K-Clip and their place in the broader TTVI strategy. Editorial by G. Nickening and J. Vogelhuber: ow.ly/61nU50Vo7V4 #StructuralHeart #TricuspidValve

Bioprosthetic vs Mechanical #AorticValve Replacement: The debate rages on! 🏥 This new study suggests mechanical may be the way to go for younger patients. Where do you stand? 🤔 🔗 Full #JACC study: jacc.org/doi/10.1016/j.…

Nice multimodality imaging of a restrictive (type 3) non-calcified severe AR during pre-#TAVR workup #echofirst #YesCCT together with Karl Dujardin Radiologie & Medische Beeldvorming AZ Delta and Deltacardio AZ Delta Roeselare #Cardiology

Now it's getting interesting! After some debate, this might finally be the right population (not too early and not too late) !!! bit.ly/2YrTRILUMINATE #ACC25 Circulation American College of Cardiology European Society of Cardiology Ritu Thamman MD Mamas A. Mamas Hany Ragy Les Jeunes du GACI Antonin Trimaille Erik Rafflenbeul

DISCOVER THE NEW ISSUE👇 📌Debating the TAVI age limit; 📌A state-of-the-art on the management of complications after valvular interventions; 📌Invasive versus echocardiography-derived gradients after #TAVI; 📌Complex PCI and TAVI; mapping interventional cardiology in Europe;

COMPARE STEMI ONE is the first RCT to assess 1-month DAPT followed by prasugrel monotherapy in STEMI patients. Also evaluated OCT-guided vs. angiography-guided staged PCI for non-culprit lesions. Protocol published 👇eurointervention.pcronline.com/article/prasug… #DAPT #STEMI #OCT #PCI #rctst

🤝 De hartchirurgen van AZ Sint-Jan Brugge AV en AZ Delta werken voortaan samen in het West-Vlaams Centrum Hartchirurgie. Zo kunnen we alle mogelijke vormen van hartchirurgie bij volwassenen aanbieden. Minister Frank Vandenbroucke juicht deze samenwerking toe. 👉 bit.ly/409QAH1

This high pacemaker rate at discharge underscores a trade-off: the JenaValve’s efficacy in treating high-risk AR patients, where surgical options are limited, comes at the cost of increased conduction disturbances. While AR patients may inherently face higher risk of PM implants

A day in the cathlab: two nice cases at high risk of coronary obstruction during #TAVR: one native, one bioprosthetic valve #YesCCT. Role of TOE #echofirst nicely illustrated. Hartcentrum AZ Delta